
CureVac, covid-19, and economic statecraft: Lessons for Europe
Trump’s bid for CureVac should spur Europeans to strengthen their investment screening rules – and signal to China and the US that unwanted takeovers will cost them
Trump’s bid for CureVac should spur Europeans to strengthen their investment screening rules – and signal to China and the US that unwanted takeovers will cost them
European countries and businesses are unlikely to escape the impact of US extraterritorial measures on China, Russia, and Turkey.
Washington and Beijing seem to interpret European inaction as weakness and an invitation for greater coercion in pursuit of their economic and geopolitical interests